• Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4

  2026-05-19

  This study uncovers how berberine inhibits senescence-associated secretory phenotype (SASP) inflammation in atherosclerosis through the RXRα/PPARγ/NEDD4 signaling pathway. The findings highlight a mechanistic link between anti-aging interventions and modulation of macrophage-driven vascular inflammation, offering new directions for targeted research in age-related cardiovascular disease.

• Apicidin: Selective Histone Deacetylase Inhibitor Evidence R

  2026-05-18

  Apicidin is a potent, selective histone deacetylase inhibitor with robust anti-proliferative and anti-angiogenesis effects in preclinical models. Mechanistically, it targets HDAC3 and HDAC6, modulating chromatin structure and gene expression. Use in research requires precise workflow integration and awareness of its emerging mycotoxin status.

• TaqI Restriction Endonuclease: Fast Protocols for DNA Digest

  2026-05-18

  TaqI Restriction Endonuclease (SKU K3053) enables rapid, sequence-specific digestion of plasmid, PCR, and genomic DNA, accelerating workflows that demand quick and reliable DNA cleavage. Optimized for research applications, TaqI is not suitable for diagnostic or clinical use. Its built-in buffer dyes further streamline downstream electrophoresis and analysis.

• NF-κB/Apaf1/caspase-9 Axis Drives Tubular Inflammation in Se

  2026-05-17

  This study elucidates a sequential NF-κB/Apaf1/caspase-9 pathway that suppresses autophagy, thereby amplifying tubular inflammation and apoptosis in septic acute kidney injury (AKI). The findings highlight the central role of tubular epithelial cell-driven cytokine signaling and suggest new molecular targets for therapeutic intervention.

• Erastin as a Ferroptosis Inducer: Protocols, Use Cases, and

  2026-05-16

  Erastin, a benchmark ferroptosis inducer, empowers cancer biology research with precision control over iron-dependent cell death pathways. This guide delivers actionable protocols, troubleshooting insights, and advanced workflow enhancements for leveraging Erastin in oxidative stress and RAS-mutant tumor studies.

• Applied Workflows with (-)-Arctigenin: MEK1 Inhibition & Tum

  2026-05-15

  Leverage (-)-Arctigenin as a precision MEK1 inhibitor and iNOS expression blocker to dissect tumor microenvironment signaling and optimize cell-based assays. This guide delivers actionable protocol enhancements, troubleshooting, and translational insights for advanced breast cancer and inflammatory disease models.

• ATRX Deficiency Sensitizes Glioma to Selective PDGFR Inhibit

  2026-05-15

  This study demonstrates that ATRX-deficient high-grade glioma cells display heightened sensitivity to receptor tyrosine kinase and PDGFR inhibitors. The findings suggest integrating ATRX mutation status into the design and interpretation of targeted therapy strategies for glioblastoma, with implications for improving therapeutic outcomes.

• Coptisine Modulates SIRT1 Ubiquitination to Alleviate PCOS i

  2026-05-14

  This study elucidates how Jiao-tai-wan (JTW) and its component coptisine ameliorate polycystic ovary syndrome (PCOS) through suppression of SIRT1 ubiquitination, impacting mitochondrial cholesterol import and ovarian steroidogenesis. Utilizing a DHEA-induced PCOS rat model, the findings reveal a targeted mechanism with potential translational value for PCOS research and therapy.

• Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4

  2026-05-14

  This study uncovers how berberine attenuates senescence-associated secretory phenotype (SASP)-related inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. The findings highlight a mechanistic link between berberine, ubiquitin-mediated GATA4/p62 degradation, and repression of chronic vascular inflammation, providing a new angle for targeting age-related cardiovascular disease.

• Lactate-Driven Ran Lactylation Regulates Astrocyte Polarizat

  2026-05-13

  This study uncovers a novel mechanism wherein lactate-induced lactylation of the Ran GTPase at lysine 123, regulated by SIRT1, promotes the polarization of astrocytes toward the neuroprotective A2 phenotype following oxygen-glucose deprivation/reoxygenation (OGD/R). These findings provide a mechanistic link between metabolic signaling and epigenetic regulation in the central nervous system, offering new research directions for spinal cord injury recovery.

• Cyclopamine as a Hedgehog Signaling Inhibitor: Workflows & I

  2026-05-13

  Cyclopamine, a potent Hedgehog signaling inhibitor from APExBIO, empowers precision assays in cancer research and developmental biology. This article demystifies optimized workflows, key protocol parameters, and troubleshooting tactics for probing pathway function, drawing on both recent comparative developmental studies and established best practices.

• G-1: Selective GPR30 Agonist Empowering Cardiovascular Model

  2026-05-12

  G-1, a selective GPR30 agonist, enables precise dissection of rapid estrogen signaling in cardiovascular, oncology, and immunology research. Its benchmark selectivity, robust DMSO solubility, and proven in vivo efficacy position it as an indispensable tool for translational and mechanistic studies.

• Apicidin: Precision Histone Deacetylase Inhibitor Workflows

  2026-05-12

  Apicidin is a powerful, selective histone deacetylase inhibitor enabling advanced epigenetic and toxicology research. This article delivers hands-on protocols, troubleshooting insights, and actionable guidance for maximizing Apicidin’s utility in cancer and reproductive models.

• Degarelix Acetate in Prostate Cancer: Study Findings and Res

  2026-05-11

  This article reviews the innovation and clinical impact of degarelix acetate, a third-generation GnRH antagonist for advanced prostate cancer. By preventing testosterone surges and offering rapid medical castration, degarelix addresses key limitations of earlier therapies, with comparative safety and efficacy established in pivotal trials.

• Tioconazole in Antifungal Research: Molecular Mechanisms & M

  2026-05-11

  Explore the advanced antifungal mechanism of Tioconazole and its integration into cutting-edge fungal infection models. This article reveals new research perspectives on the ergosterol biosynthesis pathway and assay optimization, providing a unique, in-depth resource for antifungal medication development.

16499 records 1/1100 page Next 12345 下5页 Last page